Metraipolis › archive › dc_8bfeb0edd0f1

Biomaterial Strategies for Three-Dimensional Bioprinting and Drug Delivery Application — Europe PMC PMID:42279839

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279839
DOI
10.3390/ma19112186
License (as archived)
solo-consultazione
Archived
2026-10-10T00:38:58.704Z
SHA-256 of the archived text
8bf46aaa29815c50236c32ce71f1a2db5582ed92beb04212f1502bbbbfaff268
Stable URL of this page
https://metraipolis.com/documento/dc_8bfeb0edd0f1

How to cite

Biomaterial Strategies for Three-Dimensional Bioprinting and Drug Delivery Application — Europe PMC PMID:42279839 — Europe PMC (en), https://europepmc.org/article/MED/42279839 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8bfeb0edd0f1 (Metraipolis archive dc_8bfeb0edd0f1, sha256 8bf46aaa29815c50236c32ce71f1a2db5582ed92beb04212f1502bbbbfaff268)
BibTeX
@misc{dc8bfeb0edd0f1,
  title = {Biomaterial Strategies for Three-Dimensional Bioprinting and Drug Delivery Application — Europe PMC PMID:42279839},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279839},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8bfeb0edd0f1; sha256 8bf46aaa29815c50236c32ce71f1a2db5582ed92beb04212f1502bbbbfaff268},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279839. Agents can read the archived copy with the MCP tool read_document.